AVITA Medical Toekomstige groei
Future criteriumcontroles 5/6
AVITA Medical is forecast to grow earnings and revenue by 70% and 26.5% per annum respectively. EPS is expected to grow by 67.5% per annum. Return on equity is forecast to be -34.2% in 3 years.
Belangrijke informatie
70.0%
Groei van de winst
67.5%
Groei van de winst per aandeel
Biotechs winstgroei | 27.1% |
Inkomstengroei | 26.5% |
Toekomstig rendement op eigen vermogen | -34.2% |
Dekking van analisten | Good |
Laatst bijgewerkt | 01 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Oct 04AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 11AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Jul 18Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?
Jun 18Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding
Apr 12AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%
Feb 02The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%
Oct 20Avita Medical appoints James Corbett as CEO
Sep 29AVITA Medical says trial evaluating its RECELL system to treat vitiligo met main goal
Sep 12Avita's burn therapy Recell gets insurance coverage in Japan following approval
Sep 01AVITA Medical GAAP EPS of -$0.25 beats by $0.15, revenue of $8.34M beats by $1.18M
Aug 11AVITA Medical Is Interesting, But Not Just Yet
Dec 21AVITA Medical reports preliminary Q2 revenue in-line with consensus
Jan 12AVITA: COVID-19's Impact
Nov 17Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 136 | 0 | 8 | 10 | 8 |
12/31/2025 | 101 | -25 | -21 | -19 | 10 |
12/31/2024 | 68 | -52 | -46 | -42 | 11 |
6/30/2024 | 54 | -50 | -58 | -53 | N/A |
3/31/2024 | 51 | -45 | -52 | -50 | N/A |
12/31/2023 | 50 | -35 | -39 | -38 | N/A |
9/30/2023 | 45 | -34 | -32 | -31 | N/A |
6/30/2023 | 41 | -31 | -25 | -24 | N/A |
3/31/2023 | 37 | -26 | -20 | -19 | N/A |
12/31/2022 | 34 | -27 | -20 | -19 | N/A |
9/30/2022 | 32 | -30 | -21 | -21 | N/A |
6/30/2022 | 30 | -30 | -19 | -18 | N/A |
3/31/2022 | 32 | -29 | -19 | -19 | N/A |
12/31/2021 | 33 | -25 | -19 | -18 | N/A |
9/30/2021 | 31 | -22 | -20 | -19 | N/A |
6/30/2021 | 29 | -27 | -27 | -26 | N/A |
3/31/2021 | 23 | -35 | -29 | -28 | N/A |
12/31/2020 | 18 | -44 | -28 | -27 | N/A |
9/30/2020 | 16 | -49 | -27 | -26 | N/A |
6/30/2020 | 14 | -42 | -24 | -23 | N/A |
3/31/2020 | 12 | -36 | -24 | -23 | N/A |
12/31/2019 | 11 | -28 | -22 | -21 | N/A |
9/30/2019 | 8 | -23 | -22 | -21 | N/A |
6/30/2019 | 5 | -25 | -20 | -19 | N/A |
3/31/2019 | 4 | -22 | -19 | -18 | N/A |
12/31/2018 | 2 | -18 | -14 | -13 | N/A |
9/30/2018 | 1 | -15 | -13 | -13 | N/A |
6/30/2018 | 1 | -13 | -13 | -13 | N/A |
3/31/2018 | 1 | -12 | N/A | -11 | N/A |
12/31/2017 | 1 | -11 | N/A | -9 | N/A |
9/30/2017 | 1 | -10 | N/A | -8 | N/A |
6/30/2017 | 1 | -9 | N/A | -7 | N/A |
3/31/2017 | 1 | -8 | N/A | -6 | N/A |
12/31/2016 | 1 | -7 | N/A | -6 | N/A |
9/30/2016 | 1 | -8 | N/A | -6 | N/A |
6/30/2016 | 1 | -8 | N/A | -6 | N/A |
3/31/2016 | 1 | -8 | N/A | -7 | N/A |
12/31/2015 | 1 | -7 | N/A | -7 | N/A |
9/30/2015 | 1 | -6 | N/A | -5 | N/A |
6/30/2015 | 1 | -6 | N/A | -5 | N/A |
3/31/2015 | 1 | -5 | N/A | -4 | N/A |
12/31/2014 | 1 | -5 | N/A | -4 | N/A |
9/30/2014 | 2 | -5 | N/A | -5 | N/A |
6/30/2014 | 3 | -5 | N/A | -7 | N/A |
3/31/2014 | 3 | -6 | N/A | -7 | N/A |
12/31/2013 | 3 | -7 | N/A | -7 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: RCEL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Winst versus markt: RCEL is forecast to become profitable over the next 3 years, which is considered above average market growth.
Hoge groeiwinsten: RCEL is expected to become profitable in the next 3 years.
Omzet versus markt: RCEL's revenue (26.5% per year) is forecast to grow faster than the US market (8.9% per year).
Hoge groei-inkomsten: RCEL's revenue (26.5% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: RCEL is forecast to be unprofitable in 3 years.